138 related articles for article (PubMed ID: 32203954)
1. Reproductive Risk Factors of Inflammatory Breast Cancer according to Luminal, HER2-Overexpressing, and Triple-Negative Subtypes: A Case Comparison Study.
Mejri N; El Benna H; Rachdi H; Labidi S; Benna M; Daoud N; Hamdi Y; Abdelhak S; Boussen H
Oncol Res Treat; 2020; 43(5):204-210. PubMed ID: 32203954
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological risk factors associated with inflammatory breast cancer subtypes.
Atkinson RL; El-Zein R; Valero V; Lucci A; Bevers TB; Fouad T; Liao W; Ueno NT; Woodward WA; Brewster AM
Cancer Causes Control; 2016 Mar; 27(3):359-66. PubMed ID: 26797453
[TBL] [Abstract][Full Text] [Related]
3. Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.
Lambertini M; Santoro L; Del Mastro L; Nguyen B; Livraghi L; Ugolini D; Peccatori FA; Azim HA
Cancer Treat Rev; 2016 Sep; 49():65-76. PubMed ID: 27529149
[TBL] [Abstract][Full Text] [Related]
4. Association between common risk factors and molecular subtypes in breast cancer patients.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
Breast; 2013 Jun; 22(3):344-50. PubMed ID: 22981738
[TBL] [Abstract][Full Text] [Related]
5. Reproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women.
Chen L; Li CI; Tang MT; Porter P; Hill DA; Wiggins CL; Cook LS
Cancer Epidemiol Biomarkers Prev; 2016 Sep; 25(9):1297-304. PubMed ID: 27307466
[TBL] [Abstract][Full Text] [Related]
6. A cumulative index of exposure to endogenous estrogens and breast cancer by molecular subtypes in northern Mexican women.
Rojas-Lima E; Gamboa-Loira B; Cebrián ME; Rothenberg SJ; López-Carrillo L
Breast Cancer Res Treat; 2020 Apr; 180(3):791-800. PubMed ID: 32086656
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory breast cancer: a single centre analysis.
Gogia A; Raina V; Deo SV; Shukla NK; Mohanti BK; Sharma DN
Asian Pac J Cancer Prev; 2014; 15(7):3207-10. PubMed ID: 24815472
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age.
Li CI; Beaber EF; Tang MT; Porter PL; Daling JR; Malone KE
Breast Cancer Res Treat; 2013 Jan; 137(2):579-87. PubMed ID: 23224237
[TBL] [Abstract][Full Text] [Related]
9. Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women.
Islam T; Matsuo K; Ito H; Hosono S; Watanabe M; Iwata H; Tajima K; Tanaka H
Ann Oncol; 2012 Sep; 23(9):2435-2441. PubMed ID: 22328736
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy response and survival of inflammatory breast cancer by hormone receptor- and HER2-defined molecular subtypes approximation: an analysis from the National Cancer Database.
Liu J; Chen K; Jiang W; Mao K; Li S; Kim MJ; Liu Q; Jacobs LK
J Cancer Res Clin Oncol; 2017 Jan; 143(1):161-168. PubMed ID: 27704268
[TBL] [Abstract][Full Text] [Related]
11. Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer.
Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI
Horm Cancer; 2019 Jun; 10(2-3):71-76. PubMed ID: 30989580
[TBL] [Abstract][Full Text] [Related]
12. Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
Zhou J; Yan Y; Guo L; Ou H; Hai J; Zhang C; Wu Z; Tang L
Saudi Med J; 2014 Nov; 35(11):1324-30. PubMed ID: 25399208
[TBL] [Abstract][Full Text] [Related]
13. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
14. Reproductive Risk Factors Associated with Breast Cancer Molecular Subtypes among Young Women in Northern China.
Wang JM; Wang J; Zhao HG; Liu TT; Wang FY
Biomed Res Int; 2020; 2020():5931529. PubMed ID: 32337260
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of epidemiological factors by breast tumor subtypes in Korean women: a case-case study.
Song N; Choi JY; Sung H; Chung S; Song M; Park SK; Han W; Lee JW; Kim MK; Yoo KY; Ahn SH; Noh DY; Kang D
Int J Cancer; 2014 Aug; 135(3):669-81. PubMed ID: 24916400
[TBL] [Abstract][Full Text] [Related]
16. BMI, reproductive factors, and breast cancer molecular subtypes: A case-control study and meta-analysis.
Li H; Sun X; Miller E; Wang Q; Tao P; Liu L; Zhao Y; Wang M; Qi Y; Li J
J Epidemiol; 2017 Apr; 27(4):143-151. PubMed ID: 28142040
[TBL] [Abstract][Full Text] [Related]
17. Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies.
Jung AY; Ahearn TU; Behrens S; Middha P; Bolla MK; Wang Q; Arndt V; Aronson KJ; Augustinsson A; Beane Freeman LE; Becher H; Brenner H; Canzian F; Carey LA; ; Czene K; Eliassen AH; Eriksson M; Evans DG; Figueroa JD; Fritschi L; Gabrielson M; Giles GG; Guénel P; Hadjisavvas A; Haiman CA; Håkansson N; Hall P; Hamann U; Hoppe R; Hopper JL; Howell A; Hunter DJ; Hüsing A; Kaaks R; Kosma VM; Koutros S; Kraft P; Lacey JV; Le Marchand L; Lissowska J; Loizidou MA; Mannermaa A; Maurer T; Murphy RA; Olshan AF; Olsson H; Patel AV; Perou CM; Rennert G; Shibli R; Shu XO; Southey MC; Stone J; Tamimi RM; Teras LR; Troester MA; Truong T; Vachon CM; Wang SS; Wolk A; Wu AH; Yang XR; Zheng W; Dunning AM; Pharoah PDP; Easton DF; Milne RL; Chatterjee N; Schmidt MK; García-Closas M; Chang-Claude J
J Natl Cancer Inst; 2022 Dec; 114(12):1706-1719. PubMed ID: 35723569
[TBL] [Abstract][Full Text] [Related]
18. Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer.
van Uden DJP; van Maaren MC; Strobbe LJA; Bult P; van der Hoeven JJ; Siesling S; de Wilt JHW; Blanken-Peeters CFJM
Breast Cancer Res; 2019 Oct; 21(1):113. PubMed ID: 31623649
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for inflammatory breast cancer and other invasive breast cancers.
Schairer C; Li Y; Frawley P; Graubard BI; Wellman RD; Buist DS; Kerlikowske K; Onega TL; Anderson WF; Miglioretti DL
J Natl Cancer Inst; 2013 Sep; 105(18):1373-84. PubMed ID: 24046390
[TBL] [Abstract][Full Text] [Related]
20. Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer.
Phipps AI; Malone KE; Porter PL; Daling JR; Li CI
Cancer; 2008 Oct; 113(7):1521-6. PubMed ID: 18726992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
